Faecal and mucosal microbiota in patients with functional gastrointestinal disorders: Correlation with toll-like receptor 2/toll-like receptor 4 expression

World Journal of Gastroenterology

Volumn 23, Issue 36, 2017, Pages 6665-6673

  Dong, Li Na ^a   Wang, Jun Ping ^a   Liu, Ping ^a   Yang, Yun Feng ^a   Feng, Jing ^a   Han, Yi ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

16S rRNA gene; Gastrointestinal microbiota; High throughput sequencing; Toll like receptors

Indexed keywords

MESSENGER RNA; RNA 16S; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; BACTERIAL RNA; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

16S RRNA GENE; ADULT; AGED; ARTICLE; CARNOBACTERIACEAE; CHINESE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; FAECALIBACTERIUM; FECES MICROFLORA; FEMALE; GENE EXPRESSION; GRANULICATELLA; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; INTESTINE FLORA; IRRITABLE COLON; MALE; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUMINOCOCCACEAE; RUMINOCOCCUS; STREPTOCOCCACEAE; STREPTOCOCCUS; BACTERIUM; BIOLOGY; BIOPSY; COLON; COLONOSCOPY; FECES; GASTROINTESTINAL DISEASE; GENETICS; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PHYLOGENY; YOUNG ADULT;

ADULT; BACTERIA; BIOPSY; COLON; COLONOSCOPY; COMPUTATIONAL BIOLOGY; FECES; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 85030161714     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i36.6665     Document Type: Article

References (21)

1. Kataoka K. The intestinal microbiota and its role in human health and disease. J Med Invest 2016; 63: 27-37 [PMID: 27040049 DOI: 10.2152/jmi.63.27]
2. Ringel Y, Maharshak N, Ringel-Kulka T, Wolber EA, Sartor RB, Carroll IM. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes 2015; 6: 173-181 [PMID: 25915459 DOI: 10.1080/19490976.2015.1044711]
3. Sundin J, Rangel I, Fuentes S, Heikamp-de Jong I, Hultgren-Hörnquist E, de Vos WM, Brummer RJ. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Aliment Pharmacol Ther 2015; 41: 342-351 [PMID: 25521822 DOI: 10.1111/apt.13055]
4. Kramer CD, Genco CA. Microbiota, Immune Subversion, and Chronic Inflammation. Front Immunol 2017; 8: 255 [PMID: 28348558 DOI: 10.3389/fimmu.2017.00255]
5. de Kivit S, Tobin MC, Forsyth CB, Keshavarzian A, Landay AL. Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics. Front Immunol 2014; 5: 60 [PMID: 24600450 DOI: 10.3389/fimmu.2014.00060]
6. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J 2017; 474: 1823-1836 [PMID: 28512250 DOI: 10.1042/BCJ20160510]
7. Escobar JS, Klotz B, Valdes BE, Agudelo GM. The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. BMC Microbiol 2014; 14: 311 [PMID: 25495462 DOI: 10.1186/s12866-014-0311-6]
8. Hornef MW, Pabst O. Real friends: Faecalibacterium prausnitzii supports mucosal immune homeostasis. Gut 2016; 65: 365-367 [PMID: 26531718 DOI: 10.1136/gutjnl-2015-310027]
9. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, Ferrante M, Verhaegen J, Rutgeerts P, Vermeire S. A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63: 1275-1283 [PMID: 24021287 DOI: 10.1136/gutjnl-2013-304833]
10. Lopez-Siles M, Martinez-Medina M, Abellà C, Busquets D, Sabat-Mir M, Duncan SH, Aldeguer X, Flint HJ, Garcia-Gil LJ. Mucosaassociated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease. Appl Environ Microbiol 2015; 81: 7582-7592 [PMID: 26296733 DOI: 10.1128/AEM.02006-15]
11. Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res 2015; 2015: 489821 [PMID: 26090491 DOI: 10.1155/2015/489821]
12. Guo WT, Liu P, Dong LN, Wang JP. [The correlation study between the changes of intestinal mucosa predominant bacteria and Toll-like receptor 2, Toll-like receptor 4 gene expressions in diarrhea-predominant irritable bowel syndrome patients]. Zhonghua Neike Zazhi 2016; 55: 541-543 [PMID: 27373290 DOI: 10.3760/cma.j.issn.0578-1426.2016.07.011]
13. Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermúdez-Humarán LG. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol 2015; 15: 67 [PMID: 25888448 DOI: 10.1186/s12866-015-0400-1]
14. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011; 332: 974-977 [PMID: 21512004 DOI: 10.1126/science.1206095]
15. West CE, Rydén P, Lundin D, Engstrand L, Tulic MK, Prescott SL. Gut microbiome and innate immune response patterns in IgEassociated eczema. Clin Exp Allergy 2015; 45: 1419-1429 [PMID: 25944283 DOI: 10.1111/cea.12566]
16. Tomlinson G, Chimalapati S, Pollard T, Lapp T, Cohen J, Camberlein E, Stafford S, Periselneris J, Aldridge C, Vollmer W, Picard C, Casanova JL, Noursadeghi M, Brown J. TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins. J Immunol 2014; 193: 3736-3745 [PMID: 25172490 DOI: 10.4049/jimmunol.1401413]
17. Marcial G, Villena J, Faller G, Hensel A, de Valdéz GF. Exopolysaccharide-producing Streptococcus thermophilus CRL1190 reduces the inflammatory response caused by Helicobacter pylori. Benef Microbes 2017; 8: 451-461 [PMID: 28504579 DOI: 10.3920/BM2016.0186]
18. Ekmekciu I, von Klitzing E, Fiebiger U, Neumann C, Bacher P, Scheffold A, Bereswill S, Heimesaat MM. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment. Front Cell Infect Microbiol 2017; 7: 167 [PMID: 28529928 DOI: 10.3389/fcimb.2017.00167]
19. York J, Fisahn C, Chapman J. Vertebral Osteomyelitis Due to Granulicatella Adiacens, a Nutritionally Variant Streptococci. Cureus 2016; 8: e808 [PMID: 27800289]
20. Uccello M, Malaguarnera G, Basile F, D'agata V, Malaguarnera M, Bertino G, Vacante M, Drago F, Biondi A. Potential role of probiotics on colorectal cancer prevention. BMC Surg 2012; 12 Suppl 1: S35 [PMID: 23173670 DOI: 10.1186/1471-2482-12-S1-S35]
21. Sánchez B, Delgado S, Blanco-Míguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res 2017; 61: [PMID: 27500859 DOI: 10.1002/mnfr.201600240]